Avalyn Pharma Inc. Common Stock (AVLN) vs Kardigan, Inc. (KARD)

A side-by-side comparison of Avalyn Pharma Inc. Common Stock and Kardigan, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Avalyn Pharma Inc. Common Stock logo
AVLN
Avalyn Pharma Inc. Common Stock
$1.13B
$25.52HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Kardigan, Inc. logo
KARD
Kardigan, Inc.
$1.15B
$12.85HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

Total return — AVLN vs KARD

growth of $100 · dividends reinvested · last 1y
AVLN -14.1% (-14.1%/yr)KARD -30.7% (-30.7%/yr)AVLN compounded faster over this window
6080100120Start $100$86$69
AVLN KARD

AVLN vs KARD: by the numbers

  • •KARD is the larger company ($1.15B vs $1.13B market cap).

Metrics side by side

Valuation

MetricAVLNKARD
P/B ratio2.841.87

Profitability

MetricAVLNKARD
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROIC-67.73%-57.11%

Go deeper

Full AVLN analysisFull KARD analysisInteractive comparison tool

Dig into the metrics

Avalyn Pharma Inc. Common Stock ROEKardigan ROEAvalyn Pharma Inc. Common Stock operating marginKardigan operating marginAvalyn Pharma Inc. Common Stock revenue growthKardigan revenue growthAvalyn Pharma Inc. Common Stock free cash flowKardigan free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.